Biotech Strategy Blog

Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Cancer Immunotherapy

  • Posts
    • AACR18
    • AACR17
    • AACR16
    • AACR15
    • AACR14
    • AACR IO
    • AAI ASGCT 2015 New Orleans
    • ASCO-SITC
    • ASCO18
    • ASCO17
    • ASCO16
    • ASCO15
    • ASCO14
    • ASCO GU18
    • ASCO GI18
    • ASCO GI 2017
    • ASCO GU CI 2016
    • ASCO GI GU 2015
    • ASCO GI GU 2014
    • ASH18
    • ASH17
    • ASH16
    • ASH15
    • ASH14
    • ASH13
    • AUA 2015
    • AUA 2014
    • BMT Tandem
    • CIML40
    • EACR
    • EAU 2015 Congress
    • EBMT15
    • ESMO IO
    • ESMO18
    • ESMO17
    • ESMO16
    • ECC 2015
    • ESMO14
    • ECC 2013
    • European Breast Cancer Conference
    • European Lung Cancer Conf
    • JPM19
    • JPM18
    • JPM17
    • JPM16
    • JPM15
    • JPM14
    • Miami Breast Cancer Conference
    • Targets17
    • Mol Targets 2016
    • Molecular Targets
    • SABCS18
    • SABCS17
    • SABCS16
    • SABCS15
    • SABCS14
    • SABCS13
    • SGO
    • SITC 2018
    • SITC 2017
    • SITC 2016
    • SITC 2015
    • SITC 2014
    • WCLC
  • About
    • Contact
  • Interviews
  • GI19 GU19
  • IO
  • Novel Targets
  • Premium Content
  • Pricing
  • Login

  • ASCO GU19 Renal Cancer Review

    Read more

  • A look at what’s new in GU malignancies

    Read more

  • New developments in Prostate Cancer

    Read more

  • New developments in Multiple Myeloma

    Read more

  • Can we target p53 therapeutically?

    Read more

  • Book Review – L’Immunothérapie des cancers

    Read more

  • New developments in cytokines as immune modulators

    Read more

  • How do we improve on 1st Generation T cell bispecifics?

    Read more

  • Insights from the ASCO GI19 conference

    Read more
E

ASCO GU19 Renal Cancer Review

What's hot in renal cancers? We take a look at what to expect at ASCO GU19 and offer insights on the emerging data

View post
E

A look at what’s new in GU malignancies

What can we learn from the key trials being presented at ASCO GU19 in San Francisco?

View post
E

New developments in Prostate Cancer

A review of key abstracts in prostate cancer expected at ASCO GU19 in San Francisco

View post

Terms of Use & Privacy Policy
Copyright © 2010-19 Biotech Strategy Blog

Sign Up for New Post Alerts
error: Content is protected !!